AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35786815 — intervention group
Group type: EXPERIMENTAL
Intervention: Symfony group
Number of subjects: 88
Study 35786815 — intervention group
Group type: EXPERIMENTAL
Intervention: LDI and BFC Rad
Number of subjects: 88
Study 34352073 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart glasses group
Number of subjects: 116
Study 34352073 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116
Study 35145945 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM-based health intervention
Number of subjects: 400
Study 33086597 — intervention group
Group type: EXPERIMENTAL
Intervention: 1–2 meals per day
Number of subjects: 800
Study 33086597 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat milk consumption
Number of subjects: 800
Study 33086597 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit consumption
Number of subjects: 800
Study 33086597 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable consumption 1–2 times/week
Number of subjects: 800
Study 33730517 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 g·kg‐1 body mass sodium bicarbonate (NaHCO3)
Number of subjects: 11
Study 33730517 — intervention group
Group type: COMPARATOR
Intervention: 0.03 g·kg‐1 body mass sodium chloride (PLA)
Number of subjects: 11
Study 34514494 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial invasive treatment (INV)
Number of subjects: 5179
Study 34514494 — intervention group
Group type: COMPARATOR
Intervention: Initial conservative treatment (CON)
Number of subjects: 5179
Study 32154876 — intervention group
Group type: EXPERIMENTAL
Intervention: DCD parent questionnaire (DCDQ) assessment
Number of subjects: 11814
Study 35382856 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosquito Shield™, a spatial repellent incorporating transfluthrin on a plastic sheet
Number of subjects: 1920
Study 35382856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1920
Study 33386335 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU) every 3 months for 18 months
Number of subjects: 3046
Study 33386335 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 3 months for 18 months
Number of subjects: 3046
Study 33386335 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU) with dietary calcium intake >300 mg/day
Number of subjects: 3046
Study 33386335 — intervention group
Group type: COMPARATOR
Intervention: Placebo with dietary calcium intake >300 mg/day
Number of subjects: 3046
Study 33386335 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU)
Number of subjects: 3046
Study 33386335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3046
Study 32827416 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliances (FOAs) worn for 2 to 3 years
Number of subjects: 115
Study 32827416 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliances (FOAs) worn for 1 to 1.5 years
Number of subjects: 115
Study 32827416 — intervention group
Group type: COMPARATOR
Intervention: Control group (no orthodontic treatment)
Number of subjects: 115
Study 32827416 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliances (FOAs) worn for up to 1.5 years
Number of subjects: 115
Study 32827416 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliances (FOAs) worn for more than 1.5 years
Number of subjects: 115
Study 35672703 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent screening and treatment (ISTi)
Number of subjects: 757
Study 35672703 — intervention group
Group type: COMPARATOR
Intervention: Passive case detection (PCDi)
Number of subjects: 757
Study 33136301 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored music listening intervention
Number of subjects: 0
Study 33136301 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 34665230 — intervention group
Group type: EXPERIMENTAL
Intervention: Pea protein
Number of subjects: 15
Study 34665230 — intervention group
Group type: COMPARATOR
Intervention: Casein
Number of subjects: 15
Study 34697129 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab
Number of subjects: 8824
Study 34697129 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8824
Study 33367483 — intervention group
Group type: EXPERIMENTAL
Intervention: GPLEMMA method for estimating GxE heritability
Number of subjects: 500000
Study 33367483 — intervention group
Group type: COMPARATOR
Intervention: Whole-genome regression approach (LEMMA)
Number of subjects: 500000
Study 32416803 — intervention group
Group type: COMPARATOR
Intervention: 0% CSM (control)
Number of subjects: 300
Study 32416803 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% CSM (CSM100)
Number of subjects: 300
Study 32416803 — intervention group
Group type: EXPERIMENTAL
Intervention: 13.46% CSM or more
Number of subjects: 300
Study 32416803 — intervention group
Group type: EXPERIMENTAL
Intervention: 20.18% CSM
Number of subjects: 300
Study 32416803 — intervention group
Group type: EXPERIMENTAL
Intervention: 20.18% and 26.91% CSM
Number of subjects: 300
Study 35737923 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide 150 mg daily
Number of subjects: 760
Study 35737923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 760
Study 32493693 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral roxadustat three times weekly
Number of subjects: 303
Study 32493693 — intervention group
Group type: COMPARATOR
Intervention: Darbepoetin alfa injections once weekly
Number of subjects: 303
Study 35088189 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally stapled Kono-S anastomosis
Number of subjects: 0
Study 35088189 — intervention group
Group type: COMPARATOR
Intervention: Stapled ileocolic side-to-side anastomosis
Number of subjects: 0
Study 34251730 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-A1 IgM
Number of subjects: 286
Study 34251730 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-B IgM
Number of subjects: 286
Study 34251730 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC analysis for anti-B IgM
Number of subjects: 286
Study 34251730 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC analysis for anti-A1 IgM
Number of subjects: 286
Study 34147344 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IH)
Number of subjects: 92
Study 34147344 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 32259260 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency repetitive transcranial magnetic stimulation
Number of subjects: 0
Study 32259260 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35643391 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 1084
Study 35643391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1084
Study 35643391 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of 6 RCT
Number of subjects: 1084
Study 33795790 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual expression
Number of subjects: 96
Study 33795790 — intervention group
Group type: COMPARATOR
Intervention: Electric pumping
Number of subjects: 96
Study 32290490 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training (Zumba Fitness®)
Number of subjects: 98
Study 32290490 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Training (Zumba Fitness® + muscle-strengthening workout)
Number of subjects: 98
Study 32290490 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 98
Study 34019431 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin HIPEC (800 mg/m2 for 90 minutes)
Number of subjects: 98
Study 34019431 — intervention group
Group type: COMPARATOR
Intervention: Standard arm (no HIPEC)
Number of subjects: 98
Study 34019431 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin HIPEC
Number of subjects: 98
Study 33334453 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter Ablation (CA)
Number of subjects: 66
Study 33334453 — intervention group
Group type: COMPARATOR
Intervention: Medical Rate Control (MRC)
Number of subjects: 66
Study 35319004 — intervention group
Group type: EXPERIMENTAL
Intervention: Centralized loading (weighted vest)
Number of subjects: 17
Study 35319004 — intervention group
Group type: COMPARATOR
Intervention: Peripheral loading (straight barbell)
Number of subjects: 17
Study 35319004 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions (centralized and peripheral)
Number of subjects: 17
Study 33986339 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of peers' gender and racial identities
Number of subjects: 0
Study 33986339 — intervention group
Group type: COMPARATOR
Intervention: Demography-agnostic networks
Number of subjects: 0
Study 32090767 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived risk assessment in men
Number of subjects: 714
Study 32090767 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived risk assessment in women
Number of subjects: 714
Study 32090767 — intervention group
Group type: COMPARATOR
Intervention: Comparison of risk perception between genders
Number of subjects: 714
Study 32090767 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression modeling for men
Number of subjects: 714
Study 32090767 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression modeling for women
Number of subjects: 714
Study 35691486 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention designed to promote national recommendations (N=24,657)
Number of subjects: 24931
Study 35691486 — intervention group
Group type: COMPARATOR
Intervention: Usual activity comparison (N=24,674)
Number of subjects: 24931
Study 35691486 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 24931
Study 34370319 — intervention group
Group type: EXPERIMENTAL
Intervention: New donor hierarchy
Number of subjects: 250
Study 34370319 — intervention group
Group type: COMPARATOR
Intervention: Traditional donor hierarchy
Number of subjects: 250
Study 32595599 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline CRF
Number of subjects: 5869
Study 32595599 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved CRF
Number of subjects: 5869
Study 32595599 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline BMI
Number of subjects: 5869
Study 32595599 — intervention group
Group type: EXPERIMENTAL
Intervention: Low PBF at baseline
Number of subjects: 5869
Study 32595599 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CRF
Number of subjects: 5869
Study 35272405 — intervention group
Group type: EXPERIMENTAL
Intervention: Thumb-tack needles at Guanyuan (CV 4), Zusanli (ST 36), and Taiyuan (LU 9)
Number of subjects: 50
Study 35272405 — intervention group
Group type: COMPARATOR
Intervention: Sham thumb-tack needles at identical acupoints
Number of subjects: 50
Study 32242272 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D immersive informed consent (group 1)
Number of subjects: 40
Study 32242272 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D immersive informed consent (group 2)
Number of subjects: 40
Study 32242272 — intervention group
Group type: COMPARATOR
Intervention: Traditional 2D radiological images (control group)
Number of subjects: 40
Study 32242272 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D immersive informed consent (group 1 and group 2)
Number of subjects: 40
Study 33206567 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand ride hailing app (RHA) use to avoid DUI
Number of subjects: 123
Study 33206567 — intervention group
Group type: COMPARATOR
Intervention: Alternate modes of transportation (self-driving or riding in another's car)
Number of subjects: 123
Study 33206567 — intervention group
Group type: EXPERIMENTAL
Intervention: RHA use influenced by friends' disapproval of DUI
Number of subjects: 123
Study 33206567 — intervention group
Group type: EXPERIMENTAL
Intervention: RHA as primary mode of transportation to clubs
Number of subjects: 123
Study 35366072 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide + ADT
Number of subjects: 1052
Study 35366072 — intervention group
Group type: COMPARATOR
Intervention: Placebo + ADT
Number of subjects: 1052
Study 33259451 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron isomaltoside administered intravenously over 30 minutes during surgical wound closure
Number of subjects: 89
Study 33259451 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered intravenously over 30 minutes during surgical wound closure
Number of subjects: 89
Study 33259451 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron isomaltoside
Number of subjects: 89
Study 32228078 — intervention group
Group type: EXPERIMENTAL
Intervention: Triathlon prosthesis
Number of subjects: 125
Study 32228078 — intervention group
Group type: COMPARATOR
Intervention: Kinemax prosthesis
Number of subjects: 125
Study 32228078 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 125
Study 34013992 — intervention group
Group type: EXPERIMENTAL
Intervention: eptinezumab 100 mg
Number of subjects: 1072
Study 34013992 — intervention group
Group type: EXPERIMENTAL
Intervention: eptinezumab 300 mg
Number of subjects: 1072
Study 34013992 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1072
Study 36054180 — intervention group
Group type: EXPERIMENTAL
Intervention: High IRSA (UNa 19-40 mmol/L)
Number of subjects: 339
Study 36054180 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate IRSA (UNa 41-68 mmol/L)
Number of subjects: 339
Study 36054180 — intervention group
Group type: EXPERIMENTAL
Intervention: Low IRSA (UNa 69-139 mmol/L)
Number of subjects: 339
Study 32144015 — intervention group
Group type: EXPERIMENTAL
Intervention: Snodgrass procedure (Group 1, 30 patients)
Number of subjects: 60
Study 32144015 — intervention group
Group type: COMPARATOR
Intervention: Snodgraft procedure (Group 2, 30 patients)
Number of subjects: 60
Study 33813183 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-hour educational workshop and one session of individual clinical instruction
Number of subjects: 105
Study 33813183 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 105
Study 33116101 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal 0.4ml midazolam with 0.5% 3ml bupivacaine (Group A)
Number of subjects: 0
Study 33116101 — intervention group
Group type: COMPARATOR
Intervention: Control group with 0.5% 3ml bupivacaine alone (Group B)
Number of subjects: 0
Study 35918164 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative collateral score (qCS)
Number of subjects: 1813
Study 35918164 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to recanalization
Number of subjects: 1813
Study 35918164 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual collateral score (vCS)
Number of subjects: 1813
Study 35918164 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to CT angiography (CTA)
Number of subjects: 1813
Study 35918164 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between qCS and time to recanalization
Number of subjects: 1813
Study 33387606 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person pain coping skills training (PCST)
Number of subjects: 178
Study 33387606 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconference-based pain coping skills training (PCST)
Number of subjects: 178
Study 33387606 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain severity reduction associated with education level
Number of subjects: 178
Study 33387606 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain interference reduction associated with cancer type
Number of subjects: 178
Study 33387606 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain interference reduction associated with marital status
Number of subjects: 178
Study 32532354 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Stories™ intervention delivered by school staff
Number of subjects: 278
Study 32532354 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 278
Study 35789220 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone education and distribution tool through simulation training
Number of subjects: 21
Study 33270499 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilayer short-stretch bandaging (Rosidal-K®)
Number of subjects: 36
Study 33270499 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable compression velcro wrap (Circaid Reduction kit®)
Number of subjects: 36
Study 32314970 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (motivational interview calls and SMS text messaging)
Number of subjects: 164
Study 32314970 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (≥50% of scheduled calls)
Number of subjects: 164
Study 32314970 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 164
Study 32314970 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention
Number of subjects: 164
Study 34797180 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum Sealing Drainage (VSD)
Number of subjects: 0
Study 32098509 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol-compliant simulation + traditional placements (5 days of simulation prior to traditional placement)
Number of subjects: 325
Study 32098509 — intervention group
Group type: COMPARATOR
Intervention: Traditional placements
Number of subjects: 325
Study 32098509 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention-to-treat simulation + traditional placements
Number of subjects: 325
Study 35963935 — intervention group
Group type: EXPERIMENTAL
Intervention: HealthyMoms app
Number of subjects: 134
Study 33795393 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased coagulation factor VIII activity (FVIII)
Number of subjects: 0
Study 33795393 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased von Willebrand factor level (vWF)
Number of subjects: 0
Study 33795393 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased phosphorylated fibrinopeptide A level
Number of subjects: 0
Study 33795393 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased fibrinogen level
Number of subjects: 0
Study 33795393 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen and phosphorylated fibrinopeptide A
Number of subjects: 0
Study 33795393 — intervention group
Group type: EXPERIMENTAL
Intervention: FVIII and vWF
Number of subjects: 0
Study 33795393 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine to hemostatic measures
Number of subjects: 0
Study 32381181 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 61
Study 35603917 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-all
Number of subjects: 619
Study 35603917 — intervention group
Group type: COMPARATOR
Intervention: Fresh-embryo transfer
Number of subjects: 619
Study 34406271 — intervention group
Group type: COMPARATOR
Intervention: One leg, once a week TENS application
Number of subjects: 137
Study 34406271 — intervention group
Group type: COMPARATOR
Intervention: One leg, twice a week TENS application
Number of subjects: 137
Study 34406271 — intervention group
Group type: COMPARATOR
Intervention: Two legs, once a week TENS application
Number of subjects: 137
Study 34406271 — intervention group
Group type: COMPARATOR
Intervention: Two legs, twice a week TENS application
Number of subjects: 137
Study 35347555 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (2.5 g of turmeric 3×/week for 12 weeks)
Number of subjects: 28
Study 35347555 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study 32631401 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity-related health education, physical exercise, and diet control for 1 year
Number of subjects: 948
Study 32631401 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 948
Study 33198491 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 5674
Study 33198491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5674
Study 33733958 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 28
Study 33733958 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 28
Study 33733958 — intervention group
Group type: EXPERIMENTAL
Intervention: Enjoyment ratings for HIIT
Number of subjects: 28
Study 33733958 — intervention group
Group type: COMPARATOR
Intervention: Enjoyment ratings for MICT
Number of subjects: 28
Study 33440969 — intervention group
Group type: EXPERIMENTAL
Intervention: DLT with CDM
Number of subjects: 120
Study 33440969 — intervention group
Group type: EXPERIMENTAL
Intervention: Univent with CDM
Number of subjects: 120
Study 33440969 — intervention group
Group type: COMPARATOR
Intervention: DLT control
Number of subjects: 120
Study 33440969 — intervention group
Group type: COMPARATOR
Intervention: Univent control
Number of subjects: 120
Study 33440969 — intervention group
Group type: EXPERIMENTAL
Intervention: Time needed for successful intubation
Number of subjects: 120
Study 33440969 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe complications
Number of subjects: 120
Study 32223617 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Hypnotherapy (MH)
Number of subjects: 42
Study 32223617 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 42
Study 34651206 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 µg I/kg/day of iodine in oral drops given to 47 infants from their first day of life until hospital discharge
Number of subjects: 94
Study 34651206 — intervention group
Group type: COMPARATOR
Intervention: Control group: 47 infants without supplements
Number of subjects: 94
Study 33675048 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT), 8 sessions, 90 minutes each
Number of subjects: 30
Study 35779102 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 230
Study 35779102 — intervention group
Group type: COMPARATOR
Intervention: Silver-embedded occlusive dressing (control)
Number of subjects: 230
Study 33504496 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide up to 1.8 mg/day
Number of subjects: 9340
Study 33504496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9340
Study 33214048 — intervention group
Group type: EXPERIMENTAL
Intervention: HSM
Number of subjects: 106